A Study of BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma

Clinical trial NCT05430945 · UNKNOWN

Trial details

NCT number: NCT05430945
Sponsor: Zhejiang University
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Relapse Multiple Myeloma Refractory Multiple Myeloma

Start date: 2022-06-20
Primary completion: 2025-06-20
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.